Poland· PL-100409000

Adproctin

A calcium dobesilate product containing calcii dobesilas monohydricus, registered in Poland by Farmaceutyczna Spółdzielnia Pracy Galena. The same ATC class is registered in 3 of our 19 countries.

ATC C05BX01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedAdproctinATCC05BX01REGISTER NO.PL-100409000PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Calcium dobesilate is registered in 3 of 19 countries.

Countries holding a registration under ATC C05BX01 (calcium dobesilate), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 3 of them publish a price we can compare per daily dose

Calcium dobesilate · ATC C05BX01

3 / 19 countries

  • Czechiaprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Calcii dobesilas monohydricus
Manufacturer
Farmaceutyczna Spółdzielnia Pracy Galena
Country
Poland (PL)
ATC code
C05BX01
ATC class
Calcium dobesilate
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909991427917
  • gtin
    05909991427924

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Calcium dobesilate in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All calcium dobesilate products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/91f5721f-4511-4b21-a447-7b8b077a5e86
GET /v1/drugs/91f5721f-4511-4b21-a447-7b8b077a5e86?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki twarde",
  "source": "urpl",
  "strength": "500 mg",
  "packaging": "05909991427917 ¦ OTC ¦ 136074\n30 kaps.\n05909991427924 ¦ OTC ¦ 136075\n60 kaps.",
  "substance": "Calcii dobesilas monohydricus 500 mg",
  "common_name": "Calcii dobesilas monohydricus",
  "pl_product_id": "100409000",
  "pozwolenie_nr": "25840",
  "auth_procedure": "NAR",
  "authorisation_validity": "2025-04-29"
}

See everything about calcium dobesilate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.